pharmaceutical investing Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine 27 August
pharmaceutical investing Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency 14 August
pharmaceutical investing Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance 04 August
